Health Care & Life Sciences » Pharmaceuticals | Innovus Pharmaceuticals Inc.

Innovus Pharmaceuticals Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,956.20
4,827.00
4,202.60
13,701.20
6,504.10
8,279
Depreciation, Depletion & Amortization
18.60
177.50
579.70
629.90
641.90
688
Other Funds
343.50
87.20
-
-
127.20
2,988
Funds from Operations
1,167.60
1,437.50
1,538.30
2,776.70
3,418.80
4,603
Changes in Working Capital
523.30
596.20
506.50
992.40
1,057.10
1,518
Net Operating Cash Flow
644.30
841.30
1,031.70
1,784.30
2,361.70
6,121
Capital Expenditures
4.10
61.50
12.80
-
44.60
Sale of Fixed Assets & Businesses
3.70
-
-
-
-
Net Investing Cash Flow
0.40
61.50
12.80
172.10
57.50
Issuance/Reduction of Debt, Net
868.50
964.10
1,093.00
2,420.30
31.20
Net Financing Cash Flow
659.60
876.90
1,093.00
2,730.40
3,154.20
Net Change in Cash
14.90
25.90
48.40
774.00
734.90
Free Cash Flow
644.30
880.30
1,041.30
1,784.30
2,406.40
Change in Capital Stock
134.60
-
-
310.10
3,312.70
Other Uses
-
-
-
172.10
12.90

About Innovus Pharmaceuticals

View Profile
Address
8845 Rehco Road
San Diego California 92122
United States
Employees -
Website http://www.innovuspharma.com
Updated 07/08/2019
Innovus Pharmaceuticals, Inc. engages in the commercialization, licensing, and development of non-prescription medicine, and consumer care products for health and vitality, and respiratory diseases. It also provides packaged healthcare solutions through over-the-counter, medicines and consumer and health products, which it market directly or through commercial partners to primary care physicians, urologists, gynecologists and therapists, and directly to consumers through on-line channels, retailers and wholesalers. The company business model leverages the ability to acquire and in-license commercial products that are supported by scientific, and or clinical evidence, place them through it existing supply chain, retail and on-line channels.